{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:41:55Z","timestamp":1789864915146,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"USAID through Health and Development International (HDI), Norway"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13071-018-2843-3","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T12:11:06Z","timestamp":1523880666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Surveillance for lymphatic filariasis after stopping mass drug administration in endemic districts of Togo, 2010\u20132015"],"prefix":"10.1186","volume":"11","author":[{"given":"Monique Ameyo","family":"Dorkenoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bronzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degninou","family":"Yehadji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maw\u00e8ke","family":"Tchalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kossi","family":"Yakpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santrao","family":"Etassoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poukpessi","family":"Adjeloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issaka","family":"Maman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Sodahlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"2843_CR1","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","volume":"376","author":"MJ Taylor","year":"2010","unstructured":"Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet. 2010;376:1175\u201385.","journal-title":"Lancet"},{"key":"2843_CR2","unstructured":"WHO. Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases. 2013. http:\/\/www.who.int\/iris\/handle\/10665\/80245 . Accessed 4 July 2016."},{"key":"2843_CR3","first-page":"489","volume":"90","author":"WHO","year":"2014","unstructured":"WHO. Global programme to eliminate lymphatic filariasis: progress report, 2014. Wkly Epidemiol Rec. 2014;90:489\u2013504.","journal-title":"Wkly Epidemiol Rec"},{"key":"2843_CR4","first-page":"341","volume":"86","author":"International Task Force for Disease Eradication","year":"2011","unstructured":"International Task Force for Disease Eradication. Meeting of the International Task Force for Disease Eradication, April 2011. Wkly Epidemiol Rec. 2011;86:341\u201351.","journal-title":"Wkly Epidemiol Rec"},{"key":"2843_CR5","volume-title":"Building partnerships for lymphatic filariasis: strategic plan","author":"WHO","year":"1999","unstructured":"WHO. Building partnerships for lymphatic filariasis: strategic plan. Geneva: World Health Organization; 1999. http:\/\/www.who.int\/iris\/handle\/10665\/66252 . Accessed 19 Mar 2017"},{"key":"2843_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1046\/j.1365-3156.2000.00620.x","volume":"5","author":"EA Ottesen","year":"2000","unstructured":"Ottesen EA. The global programme to eliminate lymphatic filariasis. Tropical Med Int Health. 2000;5:591\u20134.","journal-title":"Tropical Med Int Health"},{"key":"2843_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1179\/000349802125001735","volume":"96","author":"JO Gyapong","year":"2002","unstructured":"Gyapong JO, Kyelem D, Kleinschmidt I, Agbo K, Ahouandogbo F, Gaba J, et al. The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries. Ann Trop Med Parasitol. 2002;96:695\u2013705.","journal-title":"Ann Trop Med Parasitol"},{"key":"2843_CR8","volume-title":"Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level","author":"WHO","year":"2005","unstructured":"WHO. Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level. 2005. http:\/\/www.who.int\/iris\/handle\/10665\/69172 . Accessed 27 June 2016."},{"key":"2843_CR9","doi-asserted-by":"publisher","first-page":"988","DOI":"10.4269\/ajtmh.2011.10-0610","volume":"84","author":"E Mathieu","year":"2011","unstructured":"Mathieu E, Dorkenoo A, Otogbe FKJ, Budge PJ, Sodahlon YK. A laboratory-based surveillance system for Wuchereria bancrofti in Togo: a practical model for resource-poor settings. Am J Trop Med Hyg. 2011;84:988\u201393.","journal-title":"Am J Trop Med Hyg"},{"key":"2843_CR10","volume-title":"Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes","author":"WHO","year":"2011","unstructured":"WHO. Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. Geneva: World Health Organization; 2011. http:\/\/www.who.int\/iris\/handle\/10665\/44580 . Accessed 5 July 2016"},{"key":"2843_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4269\/ajtmh.13-0407","volume":"90","author":"PJ Budge","year":"2014","unstructured":"Budge PJ, Dorkenoo AM, Sodahlon YK, Fasuyi OB, Mathieu E. Ongoing surveillance for lymphatic filariasis in Togo: assessment of alternatives and nationwide reassessment of transmission status. Am J Trop Med Hyg. 2014;90:89\u201395.","journal-title":"Am J Trop Med Hyg"},{"key":"2843_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/infdis\/170.1.247","volume":"170","author":"S Chanteau","year":"1994","unstructured":"Chanteau S, Moulia-Pelat JP, Glaziou P, Nguyen NL, Luquiaud P, Plichart C, et al. Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis. J Infect Dis. 1994;170:247\u201350.","journal-title":"J Infect Dis"},{"key":"2843_CR13","first-page":"263","volume":"15","author":"SL Hoti","year":"2002","unstructured":"Hoti SL, Elango A, Radjame K, Yuvaraj J, Pani SP. Detection of day blood filarial antigens by Og4C3 ELISA test using filter paper samples. Natl Med J India. 2002;15:263\u20136.","journal-title":"Natl Med J India"},{"key":"2843_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s13149-014-0408-z","volume":"108","author":"AM Dorkenoo","year":"2015","unstructured":"Dorkenoo AM, Sodahlon YK, Bronzan RN, Yakpa K, Sossou E, Ouro-Medeli A, et al. Enqu\u00eate d\u2019\u00e9valuation de la transmission de la filariose lymphatique en milieu scolaire, 3 ans apr\u00e8s l\u2019arr\u00eat du traitement de masse \u00e0 l\u2019albendazole et \u00e0 l\u2019ivermectine dans les 7 districts end\u00e9miques du Togo. Bull Soc Pathol Exot. 2015;108:181\u20137.","journal-title":"Bull Soc Pathol Exot"},{"key":"2843_CR15","first-page":"346","volume":"87","author":"WHO","year":"2012","unstructured":"WHO. Global programme to eliminate lymphatic filariasis: progress report, 2011. Wkly Epidemiol Rec. 2012;87:346\u201356.","journal-title":"Wkly Epidemiol Rec"},{"key":"2843_CR16","first-page":"303","volume-title":"Essays on African Population","author":"KM Barbour","year":"1961","unstructured":"Barbour KM. A geographical analysis of boundaries in inter-tropical Africa. In: Barbour KM, Prothero RM, editors. Essays on African Population. London: Routledge and Kegan Paul; 1961. p. 303\u201323."},{"key":"2843_CR17","first-page":"130","volume-title":"Migration in West Africa: demographic aspects. The World Bank. Report No.: 12688","author":"KC Zachariah","year":"1991","unstructured":"Zachariah KC, Conde J. Migration in West Africa: demographic aspects. The World Bank. Report No.: 12688. New York: Oxford University Press; 1991. p. 130. http:\/\/documents.worldbank.org\/curated\/en\/950061468742878256\/Migration-in-West-Africa-demographic-aspects"},{"key":"2843_CR18","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.4049\/jimmunol.145.12.4298","volume":"145","author":"GE Kwan-Lim","year":"1990","unstructured":"Kwan-Lim GE, Forsyth KP, Maizels RM. Filarial-specific IgG4 response correlates with active Wuchereria bancrofti infection. J Immun. 1990;145:4298\u2013305.","journal-title":"J Immun"},{"key":"2843_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0035-9203(01)90233-0","volume":"95","author":"ND Alexander","year":"2001","unstructured":"Alexander ND, Bockarie MJ, Dimber ZB, Griffin L, Kazura JW, Alpers MP. Migration and dispersal of lymphatic filariasis in Papua New Guinea. Trans R Soc Trop Med Hyg. 2001;95:277\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2843_CR20","first-page":"594","volume":"40","author":"WHO","year":"2017","unstructured":"WHO. Global programme to eliminate lymphatic filariasis: progress report, 2016. Wkly Epidemiol Rec. 2017;40:594\u2013608.","journal-title":"Wkly Epidemiol Rec"},{"key":"2843_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1475-2875-7-73","volume":"7","author":"DH Mueller","year":"2008","unstructured":"Mueller DH, Wiseman V, Bakusa D, Morgah K, Dar\u00e9 A, Tchamdja P. Cost-effectiveness analysis of insecticide-treated net distribution as part of the Togo Integrated Child Health Campaign. Malaria J. 2008;7:73.","journal-title":"Malaria J"},{"key":"2843_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1475-2875-12-162","volume":"12","author":"ER Stevens","year":"2013","unstructured":"Stevens ER, Aldridge A, Degbey Y, Pignandi A, Dorkenoo MA, Hugelen-Padin J. Evaluation of the 2011 long-lasting, insecticide-treated net distribution for universal coverage in Togo. Malar J. 2013;12:162.","journal-title":"Malar J"},{"key":"2843_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/1475-2875-13-260","volume":"13","author":"RE Desrochers","year":"2014","unstructured":"Desrochers RE, Siekmans K, Berti PR, Bramhill K, Buchan SA, Battah GK, et al. Effectiveness of post-campaign, door-to-door, hang-up, and communication interventions to increase long-lasting, insecticidal bed net utilization in Togo (2011\u20132012): a cluster randomized, control trial. Malar J. 2014;13:260.","journal-title":"Malar J"},{"key":"2843_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/trstmh\/trv070","volume":"109","author":"IO Owusu","year":"2015","unstructured":"Owusu IO, de Souza DK, Anto F, Wilson MD, Boakye DA, Bockarie MJ, Gyapong JO. Evaluation of human and mosquito based diagnostic tools for defining endpoints for elimination of Anopheles transmitted lymphatic filariasis in Ghana. Trans R Soc Trop Med Hyg. 2015;109:628\u201335.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2843_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4269\/ajtmh.13-0089","volume":"89","author":"GJ Weil","year":"2013","unstructured":"Weil GJ, Curtis KC, Fakoli L, Fischer K, Gankpala L, Lammie PJ, et al. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. Am J Trop Med Hyg. 2013;89:11\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"2843_CR26","doi-asserted-by":"publisher","first-page":"e0005703","DOI":"10.1371\/journal.pntd.0005703","volume":"11","author":"CB Chesnais","year":"2017","unstructured":"Chesnais CB, Awaca-Uvon N-P, Bolay FK, Boussinesq M, Fischer PU, Gankpala L, et al. A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa. PLoS Negl Trop Dis. 2017;11:e0005703.","journal-title":"PLoS Negl Trop Dis"},{"key":"2843_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/infdis\/175.2.489","volume":"175","author":"L Nicolas","year":"1997","unstructured":"Nicolas L, Plichart C, Nguyen LN, Moulia-Pelat JP. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. J Infect Dis. 1997;175:489\u201392.","journal-title":"J Infect Dis"},{"key":"2843_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4269\/ajtmh.2008.78.289","volume":"78","author":"DJ Tisch","year":"2008","unstructured":"Tisch DJ, Bockarie MJ, Dimber Z, Kiniboro B, Tarongka N, Hazlett FE, et al. Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. Am J Trop Med Hyg. 2008;78:289\u201393.","journal-title":"Am J Trop Med Hyg"},{"key":"2843_CR29","first-page":"12","volume-title":"Lymphatic filariasis research and control in eastern and southern Africa. Copenhagen, Denmark: Centre for Health Research and Development (DBL)","author":"CN Wamae","year":"2008","unstructured":"Wamae CN, Njenga SM. Diagnostic techniques and their role in lymphatic filariasis control programmes in eastern and southern Africa. In: Simonsen PE, Malecela MN, Michael E, Mackenzie CD, editors. Lymphatic filariasis research and control in eastern and southern Africa. Copenhagen, Denmark: Centre for Health Research and Development (DBL); 2008. p. 12\u201329."}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2843-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-018-2843-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2843-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T03:58:57Z","timestamp":1693627137000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-018-2843-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2843"],"URL":"https:\/\/doi.org\/10.1186\/s13071-018-2843-3","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,16]]},"assertion":[{"value":"12 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for the two TAS surveys were received from Ministry of Health and Social Welfare (Togo)\u2019s Bioethics Committee. Additionally, written informed consent was also obtained from all surveyed persons for the two TAS. For the ongoing surveillance considered as a routine activity of the national programme, each person included in the study was informed of the objectives of the survey and the oral consent was obtained before the blood collection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"244"}}